Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wael El-Rifai

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Molecular Cancer|March 31, 2011
Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cellsBhavatarini Vangamudi, Shoumin Zhu, Mohammed Soutto, et al.
Molecular Oncology|June 24, 2014
AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancersAhmed Katsha, Janet Arras, Mohammed Soutto, et al.
Digestive Diseases and Sciences|March 20, 2010
Esophageal adenocarcinoma: treatment modalities in the era of targeted therapyKaushik Mukherjee, A Bapsi Chakravarthy, Laura W Goff, et al.
Cancers|October 27, 2020
Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?Shayan Khalafi, Albert Craig Lockhart, Alan S Livingstone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
Resistance to TRAIL is mediated by DARPP-32 in gastric cancerAbbes Belkhiri, Shoumin Zhu, Zheng Chen, et al.
Cancers|April 30, 2021
Role of Bacterial and Viral Pathogens in Gastric CarcinogenesisManikandan Palrasu, Elena Zaika, Wael El-Rifai, et al.
Cancer Research|January 18, 2008
t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanismAbbes Belkhiri, Altaf A Dar, Alexander Zaika, et al.
Cancer Research|November 1, 2008
Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cellsAltaf A Dar, Abbes Belkhiri, Jeffrey Ecsedy, et al.
Molecular Cancer Therapeutics|February 4, 2010
Aurora kinase inhibitors--rising stars in cancer therapeutics?Altaf A Dar, Laura W Goff, Shahana Majid, et al.
Cancer|September 14, 2012
The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomasVikas Sehdev, Ahmed Katsha, Jeffrey Ecsedy, et al.
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Molecular Cancer|March 31, 2011
Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cellsBhavatarini Vangamudi, Shoumin Zhu, Mohammed Soutto, et al.
Molecular Oncology|June 24, 2014
AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancersAhmed Katsha, Janet Arras, Mohammed Soutto, et al.
Digestive Diseases and Sciences|March 20, 2010
Esophageal adenocarcinoma: treatment modalities in the era of targeted therapyKaushik Mukherjee, A Bapsi Chakravarthy, Laura W Goff, et al.
Cancers|October 27, 2020
Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?Shayan Khalafi, Albert Craig Lockhart, Alan S Livingstone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
Resistance to TRAIL is mediated by DARPP-32 in gastric cancerAbbes Belkhiri, Shoumin Zhu, Zheng Chen, et al.
Cancers|April 30, 2021
Role of Bacterial and Viral Pathogens in Gastric CarcinogenesisManikandan Palrasu, Elena Zaika, Wael El-Rifai, et al.
Cancer Research|January 18, 2008
t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanismAbbes Belkhiri, Altaf A Dar, Alexander Zaika, et al.
Cancer Research|November 1, 2008
Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cellsAltaf A Dar, Abbes Belkhiri, Jeffrey Ecsedy, et al.
Molecular Cancer Therapeutics|February 4, 2010
Aurora kinase inhibitors--rising stars in cancer therapeutics?Altaf A Dar, Laura W Goff, Shahana Majid, et al.
Cancer|September 14, 2012
The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomasVikas Sehdev, Ahmed Katsha, Jeffrey Ecsedy, et al.
Pageof 16